Microsoft Anthropic in Talks Over Custom AI Chip Deal Following 5 Billion Investment SpaceX Faces A Crucial Launch Test Ahead Of Its IPO Top CD Rates on May 23 2026 Leading Account Offers 4 APY Amid Changing Rate Landscape Bill Gates Discusses Trump Meeting Musks DOGE and Childhood in WSJ Interview 3M India Reports 202 Q4 Profit Surge and Declares 506 Per Share Dividend Including Special Payout DBS CEO Tan Su Shan Secures Sixth Place in Fortunes 2026 Most Powerful Women List Farmland Partners Inc FPI Q1 2026 Earnings EPS Falls Short of Estimates Amid Lower Farm Income SCVL Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Retail Footwear Market EuroDry Ltd Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Move ASR Q1 2026 Earnings EPS Misses Estimates Shares Dip 225 Backblaze Q1 2026 Earnings EPS Misses Estimates as Wider Loss Sends Mixed Signals Navient Q1 2026 Earnings EPS Surpasses Estimates as Stock Edges Higher Critical Metals Corp CRML Slips 375 as Key Support Level Tests Buyers Splash Beverage Group SBEV Slides 357 to 016 Testing Key Support at 015 Nuveen Select Maturities Municipal Fund Holds Steady at 935 Flat Trading Reflects Market Indecision McDonalds MCD Slips Slightly Amid Consolidation Key Support and Resistance Levels in Focus GJR Holds Steady at 2475 STRATS Trust Maintains Ground Amid Low Volume US Official Highlights Japans Role in Fentanyl Smuggling Route Raising Trade Security Concerns FTHM Q4 2025 Earnings EPS Misses Estimates as Losses Widen Ecolab ECL Holds Steady as Price Consolidates Between Key Technical Levels BDCIW Warrants Hold Steady at 045 as Support and Resistance Levels Define Trading Range Tower Semiconductor TSEM Edges Higher as Semiconductor Sector Shows Resilience Intellia Therapeutics NTLA Gains 186 as Gene Editing Stocks Find Support LanzaTech Global LNZA Slides 72 as Resistance Holds Firm Key Support in Focus Radiopharm Theranostics RADX Holds Steady at 449 Consolidation Phase for Radiopharma Play ePlus Inc PLUS Advances 21 Closing In on 93 Resistance Avalo Therapeutics AVTX Slips 15 as Stock Consolidates Between Key Support and Resistance